Research at Apotex includes the development of both generic
and innovative pharmaceuticals.
Apotex has more than 600 generic, innovative and biotechnology products in
development. Its product line includes oral solids, liquids, injectables,
nasal sprays, ophthalmics, and inhalation solutions. New generic products
have been a critical component of Apotex’s growth and have resulted in the
development of substantial expertise in Product Development, BioClinical
Development, Regulatory & Medical Affairs and Project Management.
Research on new chemical entities is carried out by ApoPharma Inc., a
Subsidiary of Apotex, where our current focus is in the areas of hematology,
neurodegenerative diseases and psoriasis. Apotex’s first innovative drug,
Ferriprox™, is approved in over 50 countries for treating iron overload in
Thalassemia. More recently, extensive research has begun on developing
permeant iron chelators for the treatment of several neurodegenerative
diseases where the impact of modifying intracellular iron metabolism is
being studied both in animals and humans. Our newest area of research,
psoriasis, will see ApoPharma initiate clinical trials in 2008 to evaluate
the safety and efficacy of a novel dipeptide that has demonstrated a
remarkable safety profile in animal toxicity testing.
Apotex is also very active in the growing area of biotechnology through
publicly traded (TSE) Cangene Inc. It has approvals around the world for the
innovative product WinRho SDF, a second generation hyper immune globulin.
WinRho is the purest form of RhoD immunoglobulin in the world and the only
one which is licensed for IV administration in the U.S. Cangene is also
funding recombinant DNA research at Canadian universities and has built a
recombinant research facility. This research, plus others in Toronto, will
be instrumental in preparing Apotex for future biotechnology products.
R & D expenditures for Apotex in 2006 was over $178 million, representing
close to 20% of sales, placing Apotex in the top 12 research and development
companies in Canada and the top pharmaceutical company.
For more Corporate Information please visit our
Canadian site.
|
|
